Published in Arzneimittelforschung on April 01, 1994
Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci (2011) 1.74
Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin. Cancer Chemother Pharmacol (2007) 1.02
Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. J Microencapsul (2014) 0.92
Safety of Nanoparticles in Medicine. Curr Drug Targets (2015) 0.83
Voltage-dependent blockade of normal and mutant muscle sodium channels by benzylalcohol. Br J Pharmacol (2000) 0.82
Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma. Mol Cancer Ther (2014) 0.77
Polymeric Micelles as Carriers for Nerve-Highlighting Fluorescent Probe Delivery. Mol Pharm (2015) 0.77
SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSION. Shock (2016) 0.75
Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity. Invest New Drugs (2007) 0.75
Rabbit liver fructose 1,6-diphosphatase. Properties of the native enzyme and their modification by subtilisin. Arch Biochem Biophys (1972) 1.82
Extralysosomal protein degradation. Annu Rev Biochem (1986) 1.74
The involvement of calpain in the activation of protein kinase C in neutrophils stimulated by phorbol myristic acid. J Biol Chem (1986) 1.46
Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation. Proc Natl Acad Sci U S A (1987) 1.34
Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase. Proc Natl Acad Sci U S A (1985) 1.33
The calpains. Trends Neurosci (1989) 1.29
Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation. Biochem J (1995) 1.26
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology (2000) 1.25
Fructose 1,6-bisphosphatase: properties of the neutral enzyme and its modification by proteolytic enzymes. Adv Enzymol Relat Areas Mol Biol (1975) 1.21
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience (1998) 1.18
Outbreaks of hyperkeratotic dermatitis of athymic nude mice in northern Italy. Lab Anim (1997) 1.16
Role of full-length osteoprotegerin in tumor cell biology. Cell Mol Life Sci (2009) 1.14
Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology (1997) 1.12
Isozymes of protein kinase C in human neutrophils and their modification by two endogenous proteinases. J Biol Chem (1990) 1.10
Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. FEBS Lett (1997) 1.10
Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate. Proc Natl Acad Sci U S A (1987) 1.10
Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring proteinase. J Biol Chem (1986) 1.09
Conversion of neutral to alkaline liver fructose 1,6-bisphosphatase: changes in molecular properties of the enzyme. Proc Natl Acad Sci U S A (1973) 1.07
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin. Clin Cancer Res (2000) 1.06
Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C. J Biol Chem (1988) 1.05
Hyperkeratosis-associated coryneform infection in severe combined immunodeficient mice. Lab Anim (1998) 1.04
Fructose 1,6-bisphosphatase: the role of lysosomal enzymes in the modification of catalytic and structural properties. Proc Natl Acad Sci U S A (1973) 1.04
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. Mini Rev Med Chem (2011) 1.04
Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Biochem J (1996) 1.04
Cytosolic Ca2+-dependent neutral proteinases from rabbit liver: activation of the proenzymes by Ca2+ and substrate. Proc Natl Acad Sci U S A (1984) 1.04
Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer (2001) 1.03
Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase. Proc Natl Acad Sci U S A (1986) 1.03
Reversible activation of human neutrophil calpain promoted by interaction with plasma membranes. Biochem Int (1985) 1.02
Cytosolic calcium dependent proteinase of human erythrocytes: formation of an enzyme-natural inhibitor complex induced by Ca2+ ions. Biochem Biophys Res Commun (1982) 1.02
Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization. FEBS Lett (1996) 1.01
Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase. Biochem Biophys Res Commun (1985) 1.01
Epidemiological study of urinary tract stones in a northern Italian city. Br J Urol (1990) 1.00
Changes in rabbit-liver lysosomes and fructose 1,6-bisphosphatase induced by cold and fasting. Proc Natl Acad Sci U S A (1973) 0.99
Supravital exposure to propidium iodide identifies apoptosis on adherent cells. Cytometry (2001) 0.99
Evidence for an interaction between fructose 1,6-bisphosphatase and fructose 1,6-bisphosphate aldolase. Arch Biochem Biophys (1979) 0.98
Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms. Biochem Biophys Res Commun (1990) 0.97
Site-directed activation of calpain is promoted by a membrane-associated natural activator protein. Biochem J (1993) 0.96
Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe. Biochem Biophys Res Commun (1989) 0.96
Changes in activity and molecular properties of fructose 1, 6-bisphosphatase during fasting and refeeding. Proc Natl Acad Sci U S A (1974) 0.95
Echocardiographic parameters and indices in the normal beagle dog. Lab Anim (1992) 0.95
Changes in intracellular localization of calpastatin during calpain activation. Biochem J (1999) 0.95
Ca2+-dependent neutral proteinase from human erythrocytes: activation by Ca2+ ions and substrate and regulation by the endogenous inhibitor. Biochem Int (1984) 0.94
On the mechanism of inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. Arch Biochem Biophys (1982) 0.94
The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte. Cell Calcium (1994) 0.94
Characterization of three rabbit liver lysosomal proteinases with fructose 1,6-bisphosphatase converting enzyme activity. Arch Biochem Biophys (1981) 0.93
Activation of NADPH oxidase and phosphorylation of membrane proteins in human neutrophils: coordinate inhibition by a surface antigen-directed monoclonal antibody. Biochem Biophys Res Commun (1986) 0.93
Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. Biochem Biophys Res Commun (1985) 0.93
Extinction and absorption coefficients and scattering phase functions of human tissues in vitro. Appl Opt (1989) 0.92
Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains. Arch Biochem Biophys (1991) 0.92
Mechanism of action of the calpain activator protein in rat skeletal muscle. Eur J Biochem (1991) 0.92
Reversible inactivation of calpain isoforms by nitric oxide. Biochem Biophys Res Commun (1995) 0.91
Following association to the membrane, human erythrocyte procalpain is converted and released as fully active calpain. Biochim Biophys Acta (1985) 0.91
Identification of the proteolytically activated form of protein kinase C in stimulated human neutrophils. Proc Natl Acad Sci U S A (1990) 0.91
Activation by hemoglobin of the Ca2+-requiring neutral proteinase of human erythrocytes: structural requirements. Biochem Biophys Res Commun (1984) 0.90
An endogenous activator of the Ca2+-dependent proteinase of human neutrophils that increases its affinity for Ca2+. Proc Natl Acad Sci U S A (1988) 0.89
Evidence for formation of a rabbit liver aldolase--rabbit liver fructose-1,6-bisphosphatase complex. Proc Natl Acad Sci U S A (1980) 0.89
Interactions of Zn2+ and Mg2+ with rabbit liver fructose 1,6 bisphosphatase. Arch Biochem Biophys (1978) 0.89
Age-dependent degradation of calpastatin in kidney of hypertensive rats. J Biol Chem (2001) 0.89
Phosphorylation by protein kinase C of a 20-kDa cytoskeletal polypeptide enhances its susceptibility to digestion by calpain. Proc Natl Acad Sci U S A (1987) 0.89
Role of delta-PKC on the differentiation process of murine erythroleukemia cells. Biochem Biophys Res Commun (1993) 0.89
Differential expression of protein kinase C isoform genes in three murine erythroleukemia cell variants: implication for chemical induced differentiation. Biochem Biophys Res Commun (1994) 0.88
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study. Toxicol Lett (2000) 0.88
Characterization of the single peptide generated from the amino-terminus end of alpha- and beta-hemoglobin chains by the Ca2+-dependent neutral proteinase. Biochim Biophys Acta (1984) 0.88
Cytosolic calcium dependent neutral proteinase of human erythrocytes: the role of calcium ions on the molecular and catalytic properties of the enzyme. Biochem Biophys Res Commun (1982) 0.88
Phosphorylation of proteins in human neutrophils activated with phorbol myristate acetate or with chemotactic factor. Arch Biochem Biophys (1986) 0.87
Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity. Tumori (2002) 0.87
Regulation of fructose, 1,6-bisphosphatase by histidine under gluconeogenic conditions. Proc Natl Acad Sci U S A (1974) 0.87
Activation of PKC-beta isoforms mediates HNE-induced MCP-1 release by macrophages. Biochem Biophys Res Commun (2002) 0.87
Identification of an endogenous activator of calpain in rat skeletal muscle. Biochem Biophys Res Commun (1990) 0.86
Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem Biol Interact (1989) 0.86
Antisense oligodeoxynucleotide inhibition of delta protein kinase C expression accelerates induced differentiation of murine erythroleukaemia cells. Biochem J (1995) 0.86
Changes in activity of fructose-1,6-bisphosphate aldolase in livers of fasted rabbits and accumulation of crossreacting immune material. Proc Natl Acad Sci U S A (1979) 0.86
Cathepsin M: a lysosomal proteinase with aldolase-inactivating activity. Arch Biochem Biophys (1982) 0.86
Ethanol-induced effects on expression level, activity, and distribution of protein kinase C isoforms in rat liver Golgi apparatus. Chem Biol Interact (1998) 0.86
Modulation of calpastatin specificity in rat tissues by reversible phosphorylation and dephosphorylation. Biochem Biophys Res Commun (1994) 0.86
Changes in intracellular calpastatin localization are mediated by reversible phosphorylation. Biochem J (2001) 0.85
Identification of proteolytic activities in the cytosolic compartment of mature human erythrocytes. Eur J Biochem (1980) 0.85
A dual role for the Ca2+-requiring proteinase in the degradation of hemoglobin by erythrocyte membrane proteinases. Proc Natl Acad Sci U S A (1984) 0.85
Calcium-binding properties of human erythrocyte calpain. Biochem J (1997) 0.85
Protein kinase C isoforms in murine erythroleukemia cells and their involvement in the differentiation process. FEBS Lett (1994) 0.84
Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem J (2001) 0.84
Differential degradation of calpastatin by mu- and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells. FEBS Lett (2000) 0.84
Cooperation between soluble and membrane-bound proteinases in the degradation of beta-hemoglobin chains in intact human erythrocytes. Arch Biochem Biophys (1982) 0.84
Inactivation of liver aldolase in fasting rabbits: evidence for the accumulation of two different immunoreactive forms. Arch Biochem Biophys (1980) 0.83
ATP induces the release of a neutral serine proteinase and enhances the production of superoxide anion in membranes from phorbol ester-activated neutrophils. J Biol Chem (1986) 0.83
Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing. Fundam Appl Toxicol (1996) 0.83
Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res (1993) 0.83
Transformation of neutral to alkaline fructose 1,6-bisphosphatase. Converting enzyme activity in the large-particle fraction from rabbit liver. Arch Biochem Biophys (1974) 0.83
Two cytosolic, Ca2+-dependent, neutral proteinases from rabbit liver: purification and properties of the proenzymes. Arch Biochem Biophys (1984) 0.83
Localization of two lysosomal proteinases on the external surface of the lysosomal membrane. Biochem Biophys Res Commun (1982) 0.83
Isolation and partial characterization of three acidic proteinases in erythrocyte membranes. Biochem J (1979) 0.83
Correlation between levels of delta protein kinase C and resistance to differentiation in murine erythroleukemia cells. Biochem Biophys Res Commun (1996) 0.82
Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats. Neuroscience (2008) 0.82
In vitro apoptotic cell death during erythroid differentiation. Apoptosis (2004) 0.82
Modulation of rat brain calpastatin efficiency by post-translational modifications. FEBS Lett (1997) 0.82
Laser phototherapy following HpD administration in superficial neoplastic lesions. Tumori (1984) 0.81